<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2017013032307N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2017-11-19</date_registration>
      <primary_sponsor>Vice Chancellor for Research Kerman University of Medical Sciences</primary_sponsor>
      <public_title>The effect of kangaroo mother care on maternal fatigue</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of Kangaroo mother care on maternal fatigue of premature infant hospitalized in  Neonatal Intensive Care Unit (NICU)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-07-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/25208</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: To allocat  randomly the participants in two groups with 50 people in each group, permuted block randomizaton method will be used. so that 25 blocks of 4 are used. In this method, the control and intervention groups are divided into two groups A and B. The possible blocks are AABB, ABAB, BAAB, BBAA, ABBA, BABA, and they numberd from 1 to 6 respectively. Then it is extracted from the random numbers table of numbers from 1 to 6. Obviously, in the case of extraction of the zero number and the number 7 to 9 is again taken from the random number table. A block is selected proportional to the number of extracted from random number table, so that 25 blocks are specified. In the sequel, a list of 100 participants will be provided as the 25 blocks will be specified and the participant will be allocated to groups A and B in the same order as the blocks are obtained.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Fatigue.</hc_freetext>
      <i_freetext>Intervention 1: In intervention group, kangaroo mother care will be performed  for 60 minutes in a manner of which the mother, wearing sleeveless, front open gown, will sit on a chair in a comfortable position with an angel of  45 to 60 degrees; then the investigator places the infant, who has been removed from the incubator, under the gown at the mother’s cleavage in an upright, chest to chest position.To keep the infant's airway open, their head will be tilted to one side and their neck will slightly be extended. The arms and legs should be flexed in a “frog” position. The baby, naked except the diaper, a warm hat and socks, will be carried in a kangaroo position secured with a binder.&#13;
During the whole period of the intervention, the investigator will accompany the mother. Intervention will be done twice a day in late morning  and evening shifts, as the ward is less crowded, for one week. Intervention 2: In the control group there is no intervention and the control group will receive routine care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Maryam Khajouei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Razi Nursing and Midwifery, Kerman University of Medical Science, Blvd. Haftbagh Alavi</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 34 3132 5177</telephone>
        <email>nmf@kmu.ac.ir; khajoueim1@mums.ac.ir; khajouei.maryam@yahoo.com</email>
        <affiliation>Faculty of Razi Nursing and Midwifery, Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farokh Abazari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Razi Nursing and Midwifery, Kerman University of Medical Sciences, Blvd. Haftbagh Alavi</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 34 3132 5288</telephone>
        <email>f_abazari@kmu.ac.ir</email>
        <affiliation>Faculty of Razi Nursing and Midwifery, Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: primiparous mothers; mothers with the minimum age of 20 and maximums age of 35 years old; mothers with minimum literacy; mothers who their premature infants are hospitalized in NICU and those who breastfeed; the infants who are hospitalized for at least one week; infants must have the gestational age of 28- 34 weeks; single infant; infants without the use of mechanical ventilation and Birth weight&gt;1200 gr and&lt;2000 gr.&#13;
exclusion criteria: incurable mother's diseases (physically or mentally); infants with anomaly; unwillingness of mothers to participate in the trial.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>35 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F48.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other specified neurotic disorders</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In intervention group, kangaroo mother care will be performed  for 60 minutes in a manner of which the mother, wearing sleeveless, front open gown, will sit on a chair in a comfortable position with an angel of  45 to 60 degrees; then the investigator places the infant, who has been removed from the incubator, under the gown at the mother’s cleavage in an upright, chest to chest position.To keep the infant's airway open, their head will be tilted to one side and their neck will slightly be extended. The arms and legs should be flexed in a “frog” position. The baby, naked except the diaper, a warm hat and socks, will be carried in a kangaroo position secured with a binder.&#13;
During the whole period of the intervention, the investigator will accompany the mother. Intervention will be done twice a day in late morning  and evening shifts, as the ward is less crowded, for one week.</i_keyword>
      <i_keyword>In the control group there is no intervention and the control group will receive routine care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fatigue. Timepoint: Pre and post intervention (before the intervention and one week after the intervention). Method of measurement: Visual analoge scale (VAS-F).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Depression. Timepoint: Pre and post intervention (before intervention and one week after intervention). Method of measurement: Edinburgh Postnatal Depression Scale (EPDS).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for Research Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-01-25</approval_date>
        <contact_name>Ethics committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>Kerman University of Medical Sciences, Blvd. Haftbagh Alavi, Kerman Kerman  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
